Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study von Bucelli, C, Capodanno, I, Miggiano, M C, Cavazzini, F, Crescenzi, S Leonetti, Russo, S, Carmosino, I, Annunziata, M, Sorà, F, Bonifacio, M, Luciano, L, Caocci, G, Loglisci, G, Elena, C, Lunghi, F, Mullai, R, Attolico, I, Binotto, G, Crisà, E, Sportoletti, P, Di Veroli, A, Scortechini, A R, Leporace, A P, Maggi, A, Crugnola, M, Stagno, F, Sancetta, R, Murgano, P, Rapezzi, D, Luzi, D, Vincelli, D I, Galimberti, S, Bocchia, M, Fava, C, Malato, A, Abruzzese, E, Saglio, G, Specchia, G, Breccia, M, Iurlo, A, Tiribelli, M, Latagliata, R

Volltext

Management and outcome of 11 pregnancies in women with polycythemia vera von Elli, E.M., Diral, E., Gambacorti-Passerini, C., Calori, R., Carmosino, I., Breccia, M., Latagliata, R., Di Veroli, A.

Volltext

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis von El-Sayegh, Suzanne, Valecha, Gautam, Rehman, Amina, Syed, Rafeel

Volltext

Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features von BRECCIA, M, AVVISATI, G, LO-COCO, F, LATAGLIATA, R, CARMOSINO, I, GUARINI, A, DE PROPRIS, M. S, GENTILINI, F, PETTI, M. C, CIMINO, G, MANDELLI, F

Volltext

Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib von Breccia, M, Muscaritoli, M, Gentilini, F, Latagliata, R, Carmosino, I, Fanelli, F. Rossi, Alimena, G

Volltext

Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib von Breccia, M., Carmosino, I., Russo, E., Morano, S. G., Latagliata, R., Alimena, G.

Volltext

P-314 Lenalidomide in myelodysplastic syndromes with del5q: How long is enough? von Vozella, F, Latagliata, R, Carmosino, I, Volpicelli, P, Montagna, C, Romano, A, Finsinger, P, Breccia, M, Oliva, E.N, Alimena, G

Volltext

Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon von Latagliata, R., Bongarzoni, V., Carmosino, I., Mengarelli, A., Breccia, M., Borza, P.A., D'Andrea, M., D'Elia, G.M., Mecarocci, S., Morano, S.G., Petti, M.C., Mandelli, F., Alimena, G.

Volltext

Reactivation of porphyria cutanea tarda as a possible side effect of Imatinib at high dosage in chronic myeloid leukemia von Breccia, M, Latagliata, R, Carmosino, I, Mandelli, F, Alimena, G

Volltext

Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes von Latagliata, R., Oliva, E.N., Volpicelli, P., Carmosino, I., Breccia, M., Vincelli, I., Alati, C., Napoleone, L., Vozella, F., Nobile, F., Alimena, G.

Volltext

Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal von Breccia, M, Latagliata, R, Cannella, L, Carmosino, I, De Cuia, R, Frustaci, A, Stefanizzi, C, Santopietro, M, Alimena, G

Volltext

Pregnancy in patients with myelodysplastic syndromes (MDS) von Volpicelli, P, Latagliata, R, Breccia, M, Carmosino, I, Stefanizzi, C, Napoleone, L, Vozella, F, Levi, A, Natalino, F, Alimena, G

Volltext

P106 High-dose rHuEPO for the treatment of patients with low-risk myelodysplastic syndromes von Latagliata, R, Oliva, E, Volpicelli, P, Napoleone, L, Carmosino, I, Breccia, M, Stefanizzi, C, Vincelli, I, Alati, C, Vozella, F, Nobile, F, Alimena, G

Volltext

P066 Familiar occurrence of myelodysplastic sydrome with del(5q) von Napoleone, L, Latagliata, R, Breccia, M, Vozella, F, Carmosino, I, De Cuia, R, Mancini, M, Volpicelli, P, Stefanizzi, C, Cannella, L, Mercanti, C, Alimena, G

Volltext

Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians von OLIVA, Esther N, NOBILE, Francesco, PASTORE, Domenico, ALATI, Caterina, LATAGLIATA, Roberto, ALIMENA, Giuliana, RONCO, Francesca, SPECCHIA, Giorgina, IMPERA, Stefana, BRECCIA, Massimo, VINCELLI, Lolanda, CARMOSINO, Ida, GUGLIELMO, Patrizia

Volltext

P125 Pregnancy in patients with myelodysplastic syndromes (MDS) von Volpicelli, P, Latagliata, R, Breccia, M, Carmosino, I, Stefanizzi, C, Iannella, E, Levi, A, Natalino, F, Alimena, G

Volltext

Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter? von Di Veroli, Ambra, Campagna, Alessia, De Muro, Marianna, Maurillo, Luca, Trawinska, Malgorzata Monika, LeonettiCrescenzi, Sabrina, Petriccione, Luca, Romano, Atelda, D’Addosio, Ada, Cenfra, Antonia, Montanaro, Marco, Felici, Stefano, Andriani, Alessandro, Carmosino, Ida, Niscola, Pasquale, Montefusco, Enrico, Breccia, Massimo, Latagliata, Roberto

Volltext

Identification of risk factors in atypical chronic myeloid leukemia von Breccia, M, Biondo, F, Latagliata, R, Carmosino, I, Mandelli, F, Alimena, G

Volltext

Ogilvie's syndrome in acute myeloid leukemia : pharmacological approach with neostigmine von BRECCIA, M, GIRMENIA, C, MECAROCCI, S, CARTONI, C, CARMOSINO, I, TAFURI, A, ALIMENA, G

Volltext

P142 Darbepoetin for the treatment of anemia of myelodysplastic syndromes: efficacy and quality of life von Oliva, E.N, Latagliata, R, Danova, M, Specchia, G, Impera, S, Rovati, B, Vincelli, I, Liso, V, Alimena, G, Ronco, F, Carmosino, I, Risitano, A, Breccia, M, Nobile, F

Volltext